[1]Vahedi A,Azimpouran M,Ghavidel A ,et al. Synchronousgallbladder squamous cell carcinoma and adenocarcinoma both as primary tumors in one patient. IntJ Surg Case Rep,2018,45(12):1-3. [2]陈晨,张东,王林,等. 原发性胆囊癌根治术的临床疗效和预后分析. 中华消化外科杂志, 2019,18(2):128-134. [3]Yasufumi S ,Hiroshi O ,Makoto Y ,et al. Gallbladder metastasis of renal clear cell carcinoma 15 years after primary cancer excision: a case report.Int J Surg Case Rep, 2018,45(29):1-3. [4]奇丽霞,林澜,白旭,等. 常规MRI结合扩散加权成像评估胆囊癌T分期并判断其组织学分级. 中华肝胆外科杂志,2019,25(10):741-745. [5]黄海,何承祥,肖诗铭,等. 急性胆囊炎与胆囊癌影像学的诊断鉴别分析. 中国CT和MRI杂志,2014,26(8):49-51. [6]曾红英,李金莲. 胆囊癌的超声造影表现. 实用肝脏病杂志,2018,21(4):645-646. [7]中华消化杂志编辑委员会,中华医学会消化病学分会肝胆疾病协作组. 中国慢性胆囊炎、胆囊结石内科诊疗共识意见(2018年). 中华消化杂志,2019,39(2):73-79. [8]中华医学会外科学分会胆道外科学组,中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版). 中华外科杂志,2020,58(4):243-251. [9]朱斌,蔡权宇,俞文隆,等. 胆囊癌合并胆管侵犯手术治疗60例临床分析. 中华外科杂志,2020,58(10):801-805. [10] 周迪,全志伟. 以肿瘤学理念审视胆囊癌的综合治疗. 中华外科杂志,2020,58(1):801-805. [11] 吕文才,邹运,温爽,等. 中国胆囊癌发病率和流行趋势分析. 中华消化外科杂志,2019,18(2):186-189. [12] Gomes A F ,Fernandes S ,Martins J,et al. Carcinoma of the gallbladder presenting as haemorrhagic cholecystitis. BMJ Case Rep,2020,13(3):232-233. [13] Suzuki K , Abe K , Ohbu M . A resected gallbladder carcinoma coexisting with adenomyomatosis involving varied degrees of intraepithelial dysplasia: a case report and literature review. Surg Laparo Endo Per, 2018, 29(4):290-296. [14] 余红胜,沈又利,吉六舟,等. 慢性胆囊炎与壁厚型胆囊癌的CT鉴别诊断. 中国医学计算机成像杂志,2012,30(4):322-325. [15] Agrawal S , Alam N , Rastogi N , et al. Chemotherapy (CT) orchemoradiation (CTRT) in postoperative (simple cholecystectomy) carcinoma gall bladder (GBC) with residual disease, unsuitable for revision surgery. J Clin Oncol, 2019, 37(15):15594-15594. [16] Takahashi, T. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res, 2015, 10(18):6126-6133. [17] Marcus S S , Kaur J , Yadav H P . Gall bladder carcinoma (gbc): rising incidences in the Malwa belt region of Northern India a hospital based cancer registry. Int J Legal Med, 2018, 6(3):108-111. [18] Yanagisawa N , Yamashita K , Kuba T , et al. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis. Anticancer Res, 2010, 30(11):4443-4449. [19] 张东,耿智敏,陈晨,等.胆囊癌的临床分型和预后关系初步分析:多中心回顾性临床研究. 中华外科杂志,2019,57(4):258-264. [20] Rhee H , Cho E S , Nahm J H , et al. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. J Hepatol, 2021, 74( 1):109-121. |